Capital International Investors
GSK icon

Capital International Investors’s GSK GSK Stock Holding History

Capital International Investors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,066,164
Closed -$326M – 433
2022
Q3 		$326M Sell
11,066,164
-4,203,987
-28% -$159M 0.1% 194
2022
Q2 		$831M Sell
15,270,151
-10,043
-0.1% -$554K 0.23% 114
2022
Q1 		$832M Sell
15,280,194
-14,387
-0.1% -$781K 0.19% 129
2021
Q4 		$843M Sell
15,294,581
-2,833,588
-16% -$147M 0.18% 129
2021
Q3 		$866M Sell
18,128,169
-13,227
-0.1% -$664K 0.2% 121
2021
Q2 		$903M Buy
18,141,396
+2,229,627
+14% +$107M 0.21% 111
2021
Q1 		$710M Buy
15,911,769
+1,816,931
+13% +$82.5M 0.18% 130
2020
Q4 		$648M Buy
14,094,838
+890,718
+7% +$40.9M 0.18% 130
2020
Q3 		$621M Sell
13,204,120
-1,858,794
-12% -$93.1M 0.19% 123
2020
Q2 		$768M Buy
15,062,914
+3,251,631
+28% +$167M 0.25% 105
2020
Q1 		$559M Buy
11,811,283
+7,086,750
+150% +$378M 0.23% 107
2019
Q4 		$278M Buy
4,724,533
+4,915
+0.1% +$273K 0.09% 164
2019
Q3 		$252M Buy
4,719,618
+625,533
+15% +$32.2M 0.1% 166
2019
Q2 		$205M Buy
4,094,085
+172,139
+4% +$8.64M 0.08% 190
2019
Q1 		$205M Buy
3,921,946
+2,550,666
+186% +$127M 0.09% 181
2018
Q4 		$65.5M Buy
+1,371,280
New +$67.5M 0.03% 232

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Capital International Investors's GSK Position: Q4 2022 in Review

Capital International Investors sold out of GSK (GSK) in Q4 2022, closing a stake of 11,066,164 shares — an estimated $326M sold.

Capital International Investors first reported a position in GSK in Q4 2018 and held it in 16 quarters. The position peaked at $903M in Q2 2021. 814 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Capital International Investors reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Capital International Investors sold 11,066,164 GSK shares in Q4 2022, an estimated $326M.
  • Capital International Investors first reported a position in GSK in Q4 2018 and held it in 16 quarters.
  • Capital International Investors's GSK position peaked at $903M in Q2 2021.
  • 814 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Capital International Investors's 13F filing for Q4 2022, filed 14 Feb 2023.